Arkolith/Insider Trading/EGRX/Form 4

Ratoff Steven B

DirectorEAGLE PHARMACEUTICALS, INC. (EGRX) · full profile →Form 4 · filed Apr 12, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 8, 2021Option exercise(M)2K$8.78$21K23K
Apr 8, 2021Option exercise(M)2K$8.78$21K25K
Apr 8, 2021Option exercise(M)2K$4.42$10K27K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 8, 2021Option exercise(M)2K—$00
Apr 8, 2021Option exercise(M)2K—$00
Apr 8, 2021Option exercise(M)2K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-026364) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML